NCT07567937

Brief Summary

Wrestling is a weight-classified sport in which athletes frequently apply rapid weight loss (RWL) strategies prior to competition. While the performance-related consequences of RWL have been widely investigated, its combined effects with exercise on hematological parameters and immune cell profiles remain insufficiently understood. Therefore, this study aims to examine the effects of short-term weight loss and exercise on whole blood cell parameters and lymphocyte subsets in elite wrestlers. Nine elite male wrestlers actively competing in the senior category (mean age: 22.90 ± 5.15 years; mean height: 1.75 m) voluntarily participated in this study. Athletes will achieve an average body mass reduction of 4.3% over a five-day period. Venous blood samples will be collected at 09:30 a.m. in a fasted state during two experimental phases: (1) Exercise-only phase, with blood sampling before and after exercise (BRWL1 and BRWL2); (2) Exercise plus weight loss phase, following the five-day weight loss period, with blood sampling before and after exercise (ARWL1 and ARWL2). Complete blood count parameters will be analyzed using an automated hematology analyzer, while lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, CD16/56+) will be assessed by flow cytometry. Statistical analyses will be performed with a significance level set at p \< 0.05.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 21, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 3, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2022

Completed
3.5 years until next milestone

First Submitted

Initial submission to the registry

April 22, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 5, 2026

Completed
Last Updated

May 5, 2026

Status Verified

April 1, 2026

Enrollment Period

10 months

First QC Date

April 22, 2026

Last Update Submit

April 28, 2026

Conditions

Keywords

Complete Blood CountExerciseFlow CytometryLymphocyte SubsetsImmune SystemRapid Weight Loss

Outcome Measures

Primary Outcomes (7)

  • Change in Leukocyte Count

    Change in total white blood cell (WBC) count measured from pre- to post-exercise

    Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)

  • Change in Lymphocyte Percentage

    Change in percentage of lymphocytes relative to total WBC count, measured from pre- to post-exercise.

    Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)

  • Change in CD3+ T Cell Count

    Change in absolute count of CD3+ T lymphocytes measured from pre- to post-exercise.

    Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)

  • Change in CD4+ T Cell Count

    Change in absolute count of CD4+ helper T lymphocytes measured from pre- to post-exercise.

    Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)

  • Change in CD8+ T Cell Count

    Change in absolute count of CD8+ cytotoxic T lymphocytes measured from pre- to post-exercise.

    Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)

  • Change in CD19+ B Cell Count

    Change in absolute count of CD19+ B lymphocytes measured from pre- to post-exercise.

    Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)

  • Change in CD16/56+ NK Cell Count

    Change in absolute count of CD16/56+ natural killer (NK) cells measured from pre- to post-exercise.

    Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)

Secondary Outcomes (1)

  • Change in Creatine Kinase and Lactic Acid Levels

    Pre-exercise and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)

Study Arms (2)

Exercise

OTHER

Participants performed a standardized wrestling exercise session on the first day of testing. Venous blood samples were collected pre- and post-exercise (pre-exercise: BRWL1; post-exercise: BRWL2) to evaluate hematological and lymphocyte subset responses.

Other: Exercise

Exercise + Rapid Weight Loss

OTHER

Participants underwent a 5-day rapid weight loss protocol prior to the exercise session, achieving an average body mass reduction of 4.3%. On the fifth day, the same standardized exercise protocol as Group 1 was performed, and pre- and post-exercise blood samples were collected (pre-exercise: ARWL1; post-exercise: ARWL2) to evaluate hematological and lymphocyte subset responses.

Other: ExerciseOther: Rapid Weight Loss

Interventions

Standardized wrestling exercise session; pre- and post-exercise venous blood collected

Also known as: Behavioral
ExerciseExercise + Rapid Weight Loss

5-day rapid weight loss protocol achieving average 4.3% body mass reduction

Exercise + Rapid Weight Loss

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Being between 18 and 35 years of age
  • Being clinically healthy
  • Actively competing in wrestling
  • Having regular training experience
  • No history of chronic disease
  • No musculoskeletal injury that could affect performance
  • Not using any medication or nutritional supplements that could influence hematological or biochemical parameters during the study period
  • Willing to volunteer and provide written informed consent

You may not qualify if:

  • Having any chronic disease (e.g., cardiovascular, metabolic, respiratory, or neurological disorders)
  • Having a recent musculoskeletal injury that could affect exercise performance
  • Using medications, ergogenic aids, or nutritional supplements that might influence hematological or biochemical parameters
  • Having a history of smoking or alcohol abuse
  • Failing to complete the testing procedures and training protocol required for the study
  • Not providing written informed consent
  • Withdrawing voluntarily during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Yildirim Beyazit University Sports Sciences Laboratory

Ankara, Ankara, 06000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Weight LossMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 22, 2026

First Posted

May 5, 2026

Study Start

June 21, 2021

Primary Completion

April 3, 2022

Study Completion

October 10, 2022

Last Updated

May 5, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations